ANI is introducing trimethoprim tablets, 100 mg following approval by the Food and Drug Administration.
Trimethoprim is an antibiotic used to treat bacterial infections.
ANI’s trimethoprim tablets are the generic of the Reference Listed Drug of the same established name.
[Read more: ANI intros generic Cytotec]
Trimethoprim tablets have a market value of approximately $16.8 million, according to IQVIA.
"As we continue to focus on bringing niche limited-competition products to market, we are pleased to announce the FDA approval and commercialization of trimethoprim tablets,” stated Nikhil Lalwani, president and CEO of ANI.